Kala Pharmaceuticals Stock Price on December 31, 2022
| KALA Stock | USD 6.55 0.12 1.87% |
Below is the normalized historical share price chart for Kala Pharmaceuticals extending back to July 20, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kala Pharmaceuticals stands at 6.55, as last reported on the 22nd of November, with the highest price reaching 6.55 and the lowest price hitting 6.10 during the day.
If you're considering investing in Kala Stock, it is important to understand the factors that can impact its price. At this point, Kala Pharmaceuticals is somewhat reliable. Kala Pharmaceuticals has Sharpe Ratio of 0.0481, which conveys that the firm had a 0.0481% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Kala Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Kala Pharmaceuticals' Mean Deviation of 2.28, downside deviation of 2.21, and Risk Adjusted Performance of 0.031 to check out if the risk estimate we provide is consistent with the expected return of 0.15%.
At present, Kala Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 71.2 K, whereas Total Stockholder Equity is forecasted to decline to about 7.1 M. . As of November 22, 2024, Price To Sales Ratio is expected to decline to 16.28. In addition to that, Price Earnings Ratio is expected to decline to -0.42. Kala Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2017 | 200 Day MA 6.5903 | 50 Day MA 6.0418 | Beta (2.14) |
Kala |
Sharpe Ratio = 0.0481
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KALA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Kala Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kala Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.3218 | Enterprise Value Ebitda (0.16) | Price Sales 1.157 | Shares Float 2.8 M | Wall Street Target Price 15 |
Kala Pharmaceuticals Valuation on December 31, 2022
It is possible to determine the worth of Kala Pharmaceuticals on a given historical date. On December 31, 2022 Kala was worth 33.88 at the beginning of the trading date compared to the closed value of 38.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kala Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Kala Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kala Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kala Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 16.13 | 30.49 | 13.50 | 24.84 | 28,747,259 | |
12/30/2022 | 33.88 | 44.99 | 29.17 | 38.15 | 18,760,713 |
| 32.38 | 35.30 | 28.50 | 31.95 | 6,080,527 |
| Backtest Kala Pharmaceuticals | | | Kala Pharmaceuticals History | | | Kala Pharmaceuticals Valuation | Previous | Next |
Kala Pharmaceuticals Trading Date Momentum on December 31, 2022
| On January 03 2023 Kala Pharmaceuticals was traded for 31.95 at the closing time. The top price for the day was 35.30 and the lowest listed price was 28.50 . The trading volume for the day was 6.1 M. The trading history from January 3, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 16.25% . The trading delta at closing time against the current closing price is 27.58% . |
Kala Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Kala Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kala Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kala financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kala Pharmaceuticals Stock history
Kala Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kala is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kala Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kala Pharmaceuticals stock prices may prove useful in developing a viable investing in Kala Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.4 M | 2.6 M | |
| Net Loss | -40.3 M | -42.4 M |
Kala Pharmaceuticals Quarterly Net Working Capital |
|
Kala Pharmaceuticals Stock Technical Analysis
Kala Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kala Pharmaceuticals Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Kala Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kala Pharmaceuticals November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Kala Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kala Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Kala Pharmaceuticals stock market strength indicators, traders can identify Kala Pharmaceuticals entry and exit signals to maximize returns
Kala Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kala Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kala Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kala to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.031 | |||
| Jensen Alpha | 0.0614 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0014 | |||
| Treynor Ratio | 0.2792 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Kala Stock analysis
When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |